Terms: = Liver cancer AND POT1, DKFZP586D211, 25913, ENSG00000128513, hPot1, DKFZp586D211
12 results:
1. Novel compound heterozygous STN1 variants are associated with Coats Plus syndrome.
Acharya T; Firth HV; Dugar S; Grammatikopoulos T; Seabra L; Walters A; Crow YJ; Parker APJ
Mol Genet Genomic Med; 2021 Dec; 9(12):e1708. PubMed ID: 34110109
[TBL] [Abstract] [Full Text] [Related]
2. Long noncoding RNA MEG3 blocks telomerase activity in human liver cancer stem cells epigenetically.
Jiang X; Wang L; Xie S; Chen Y; Song S; Lu Y; Lu D
Stem Cell Res Ther; 2020 Nov; 11(1):518. PubMed ID: 33256840
[TBL] [Abstract] [Full Text] [Related]
3. SERPINA3 is a key modulator of HNRNP-K transcriptional activity against oxidative stress in HCC.
Ko E; Kim JS; Bae JW; Kim J; Park SG; Jung G
Redox Biol; 2019 Jun; 24():101217. PubMed ID: 31121493
[TBL] [Abstract] [Full Text] [Related]
4. Long-Term Follow-Up of a Case with Dyskeratosis Congenita Caused by NHP2-V126M/X154R Mutation: Genotype-Phenotype Association.
Erdem M; Tüfekçi Ö; Yılmaz Ş; Alacacıoğlu İ; Ören H
Acta Haematol; 2019; 141(1):28-31. PubMed ID: 30472699
[TBL] [Abstract] [Full Text] [Related]
5. Shelterin differentially respond to oxidative stress induced by TiO
Wang H; Ni J; Guo X; Zhou T; Ma X; Xue J; Wang X
Biochem Biophys Res Commun; 2018 Sep; 503(2):697-702. PubMed ID: 29909006
[TBL] [Abstract] [Full Text] [Related]
6. Inflammatory factor receptor Toll-like receptor 4 controls telomeres through heterochromatin protein 1 isoforms in liver cancer stem cell.
Zheng Q; Xu J; Lin Z; Lu Y; Xin X; Li X; Yang Y; Meng Q; Wang C; Xiong W; Lu D
J Cell Mol Med; 2018 Jun; 22(6):3246-3258. PubMed ID: 29602239
[TBL] [Abstract] [Full Text] [Related]
7. HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2.
Wu M; Lin Z; Li X; Xin X; An J; Zheng Q; Yang Y; Lu D
Sci Rep; 2016 Oct; 6():36045. PubMed ID: 27782152
[TBL] [Abstract] [Full Text] [Related]
8. Inflammatory related gene IKKα, IKKβ, IKKγ cooperates to determine liver cancer stem cells progression by altering telomere via heterochromatin protein 1-HOTAIR axis.
An J; Wu M; Xin X; Lin Z; Li X; Zheng Q; Gui X; Li T; Pu H; Li H; Lu D
Oncotarget; 2016 Aug; 7(31):50131-50149. PubMed ID: 27367027
[TBL] [Abstract] [Full Text] [Related]
9. Cause-specific telomere factors deregulation in hepatocellular carcinoma.
El Idrissi M; Hervieu V; Merle P; Mortreux F; Wattel E
J Exp Clin Cancer Res; 2013 Sep; 32(1):64. PubMed ID: 24020493
[TBL] [Abstract] [Full Text] [Related]
10. Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers.
Kim H; Yoo JE; Cho JY; Oh BK; Yoon YS; Han HS; Lee HS; Jang JJ; Jeong SH; Kim JW; Park YN
J Hepatol; 2013 Oct; 59(4):746-52. PubMed ID: 23685049
[TBL] [Abstract] [Full Text] [Related]
11. Altered mRNA expression of telomere binding proteins (TPP1, pot1, RAP1, TRF1 and TRF2) in ulcerative colitis and Crohn's disease.
Da-Silva N; Arasaradnam R; Getliffe K; Sung E; Oo Y; Nwokolo C
Dig Liver Dis; 2010 Aug; 42(8):544-8. PubMed ID: 20061197
[TBL] [Abstract] [Full Text] [Related]
12. Telomeric 3' overhangs in chronic HBV-related hepatitis and hepatocellular carcinoma.
Lee JE; Oh BK; Choi J; Park YN
Int J Cancer; 2008 Jul; 123(2):264-272. PubMed ID: 18449889
[TBL] [Abstract] [Full Text] [Related]
